Testing for defective DNA mismatch repair in colorectal carcinoma: A practical guide

Archives of Pathology and Laboratory Medicine

Volumn 129, Issue 11, 2005, Pages 1385-1389

  Burgart, Lawrence J ^a,b  

^a MAYO CLINIC   (United States)

^b ABBOTT NORTHWESTERN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA; PROTEIN MLH1; PROTEIN MSH2;

COLON CARCINOGENESIS; COLORECTAL CARCINOMA; DNA METHYLATION; DNA REPAIR; FAMILIAL CANCER; FAMILY HISTORY; HUMAN; IMMUNOHISTOCHEMISTRY; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; PROGNOSIS; PROMOTER REGION; REVIEW; SYNDROME DELINEATION;

ADENOCARCINOMA; ALGORITHMS; BASE PAIR MISMATCH; CARRIER PROTEINS; COLORECTAL NEOPLASMS; DNA REPAIR; HUMANS; IMMUNOENZYME TECHNIQUES; MICROSATELLITE REPEATS; MIDDLE AGED; NUCLEAR PROTEINS;

EID: 27744512989     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Hamilton SR. The molecular genetics of colorectal neoplasia. Gastroenterology. 1993;105:3-7.
2. Burgart LJ. Colorectal polyps and other precursor lesions: need for an expanded view. Gastroenterol Clin North Am. 2002;31:959-970.
3. Thibodeau SN, French AJ, Cunningham JM, et al. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res. 1998;58:1713-1718.
4. Cunningham JM, Christensen ER, Tester DJ, et al. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res. 1998;58:3455-3460.
5. Hemminki A, Mecklin JP, Jarvinen H, Aaltonen LA, Joensuu H. Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy. Gastroenterology. 2000;119:921-928.
6. Coleman LW, Curtin K, Schaffer D, Leppert M, Slattery ML, Samowitz WS. Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Mod Pathol. 2001;14:83A.
7. Parc Y, Gueroult S, Mourra N, et al. Prognostic significance of microsatellite instability determined by immunohistochemical staining of MSH2 and MLH1 in sporadic T3N0M0 colon cancer. Gut. 2004;53:371-375.
8. Elsaleh H, Joseph D, Grieu F, et al. Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet. 2000; 355:1745-1750.
9. Claij N, te Riele H. Microsatellite instability in human cancer: a prognostic marker for chemotherapy? Exp Cell Res. 1999;246:1-10.
10. Ribic CM, Sargent DJ, Moore MJ, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 2003;349:247-257.
11. Fink D, Aebi S, Howell SB. The role of DNA mismatch repair in drug resistance. Clin Cancer Res. 1998;4:1-6.
12. Anthony DA, McIlwrath AJ, Gallagher WM, Edin AR, Brown R. Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells. Cancer Res. 1996;56:1374-1381.
13. Kat A, Thilly WG, Fank W-H, et al. An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair. Proc Natl Acad Sci U S A. 1993;90:6424-6428.
14. Branch P, Aquilina G, Bignami M, Karran P. Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage. Nature. 1993;362: 652-654.
15. Meyers M, Wagner MW, Hwang HS, Kinsella TJ, Boothman DA. Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses. Cancer Res. 2001;61:5193-5201.
16. Kim H, Jen J, Vogelstein B, Hamilton SR. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol. 1994;145:148-156.
17. Krishna M, Burgart LJ, French AJ, Moon-Tasson L, Halling KC, Thibodeau SN. Histopathologic features associated with microsatellite instability in colorectal carcinomas. Gastroenterology. 1996;110:A546.
18. Smyrk TC, Watson P, Kaul K, Lynch HT. Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma. Cancer. 2001;91: 2417-2422.
19. Alexander J, Watanabe T, Wu TT, Rashid A, Li S, Hamilton SR. Histopathologic identification of colon cancer with microsatellite instability. Am J Pathol. 2001;158:527-535.
20. Mecklin J-P, Järvinin H, Hakkiluoto A, et al. Frequency of hereditary non-polyposis colorectal cancer: a prospective multicenter study in Finland. Dis Colon Rectum. 1995;38:588-593.
21. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96:261-268.
22. Lynch HT, Smyrk TC, Watson P, et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology. 1993;104:1535-1549.
23. Hampel H, Frankel WL, Martin E, et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med. 2005;352:1851-1860.
24. Kievit W, de Bruin JH, Adang EM, et al. Current clinical selection strategies for identification of hereditary non-polyposis colorectal cancer families are inadequate: a meta-analysis. Clin Genet. 2004;65:308-316
25. Lipton LR, Johnson V, Cummings C, et al. Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic [published correction appears in J Clin Oncol. 2005;23:3652]. J Clin Oncol. 2004;22:4934-4943.
26. Domingo E, Laiho P, Ollikainen M, et al. BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet. 2004;41: 664-668.
27. McGivern A, Wynter CV, Whitehall VL, et al. Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer. Fam Cancer. 2004;3:101-107.